Back to Directory Ana Martinez Email amartinez@niaid.nih.gov Institution Division of AIDS Title Chief, Pharmaceutical Affairs Branch Request an Update Affiliated Studies P1069: GPO-VIR Z30 DAIDS Number 10620 Research Area Other Study Status Concluded P1114: Safety and Immunogenicity of an RSV Vaccine cps2 DAIDS Number 11948 Research Area Complications & Comorbidities Study Status Concluded IMPAACT 2000: A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID delta M2-2 in RSV-Seronegative Infants and Children DAIDS Number 12016 Research Area Complications & Comorbidities Study Status Concluded
P1114: Safety and Immunogenicity of an RSV Vaccine cps2 DAIDS Number 11948 Research Area Complications & Comorbidities Study Status Concluded
IMPAACT 2000: A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID delta M2-2 in RSV-Seronegative Infants and Children DAIDS Number 12016 Research Area Complications & Comorbidities Study Status Concluded
